Floatz logo

Clofarabine

Acute Undifferentiated Leukemia

M.D. Anderson Cancer CenterSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

33 Active assets in the Acute Undifferentiated Leukemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Fred Hutchinson Cancer Center
Phase 2BB
Cytosin-Arabinosid
Fred Hutchinson Cancer Center
Phase 3BB
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 3BB
DEXAMETHASONE
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BB
METHOTREXATE
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BB

View all 50 →

Same molecule, other indications

Clofarabine is also rated in:

acute myeloid leukemia with 11q23 abnormalitiesDormant
BB
Indicative ·
70 / 100
View asset →
acute myeloid leukemia, del(5q31-q32)Dormant
BB
Indicative ·
70 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →